# Prenatal cannabis smoke exposure alters placental development in a murine model of pregnancy

**Authors:** Tina Podinic, Maria Sunil, Andie MacAndrew, Cristina Monaco, Grace Lee, Cielle Lockington, Jim Petrik, Amica-Maria Lucas, Thane Tomy, Gregg Tomy, Joanna Kasinska, Laiba Jamshed, Alison C. Holloway, Elyanne M. Ratcliffe, Sandeep Raha

PMC · DOI: 10.1371/journal.pone.0328123 · PLOS One · 2026-03-16

## TL;DR

Prenatal cannabis smoke exposure in mice harms placental development and fetal brain growth, suggesting risks for human pregnancies.

## Contribution

A new murine model shows in vivo effects of cannabis smoke on placental structure and fetal outcomes.

## Key findings

- Cannabis smoke exposure reduced placental size and altered zonation in mice.
- Key placental markers for differentiation and function were significantly downregulated.
- Exposed offspring showed reduced brain-to-body weight ratios despite normal body weights.

## Abstract

Cannabis use during pregnancy continues to increase with smoking remaining the most common mode of consumption. While clinical studies highlight an association between prenatal cannabis use and adverse pregnancy outcomes, less is known about placental outcomes, even though many of the reported pregnancy outcomes are thought to be mediated via placental dysfunction. Here, we established a mouse model of gestational cannabis smoke exposure to investigate the impacts on fetal outcomes and placental structure and function. Pregnant CD1 mice were exposed daily to Δ9-tetrahydrocannabinol (THC)-dominant cannabis smoke (12–14% THC, 0–2% CBD) or filtered air from embryonic day (E)6.5 to E18.5 or parturition. Cannabinoid analyses in cannabis smoke-exposed, paired maternal and fetal livers revealed total THC and 11-Nor-9-carboxy-THC (THCA) concentrations of 135.95 ± 13.60 ng/g and 30.84 ± 4.68 ng/g, respectively. Moreover, Cyp1a1, a smoke-inducible enzyme, was induced by 4-fold in cannabis smoke-exposed placentae. No changes in offspring body weights were observed; however, there was a marked decrease in the brain-to-body weight ratio of exposed postnatal day 1 (PND1) offspring. Placentae from exposed dams were significantly reduced in size, with altered zonation marked by a significantly decreased junctional zone and increased labyrinth zone. Key trophoblast differentiation markers (Tfap2c, Tpbpa, Pcdh12) and placental endocrine regulators (Pl2, Igf1r) were significantly downregulated following cannabis smoke exposure in placentas. Furthermore, transcript levels of placental nutrient and vascularization markers, Glut1, Vegfa and Pparg were significantly decreased in cannabis smoke-exposed placentas. By employing a physiologically relevant platform of prenatal cannabis exposure in vivo we demonstrate the adverse effects of prenatal cannabis smoke exposure on placental structure and function as well as on fetal brain growth.

## Linked entities

- **Genes:** CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543], TFAP2C (transcription factor AP-2 gamma) [NCBI Gene 7022], Tpbpa (trophoblast specific protein alpha) [NCBI Gene 21984], PCDH12 (protocadherin 12) [NCBI Gene 51294], Prl3b1 (prolactin family 3, subfamily b, member 1) [NCBI Gene 18776], IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480], SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468]
- **Chemicals:** THC (PubChem CID 16078), 11-Nor-9-carboxy-THC (PubChem CID 107885), THCA (PubChem CID 6155526)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cyp21a1 (cytochrome P450, family 21, subfamily a, polypeptide 1) [NCBI Gene 13079] {aka 21-OH, 21OH, 21OHA, 21OHB, CYP21OH-A, Cyp21}, Tsc22d3 (TSC22 domain family, member 3) [NCBI Gene 14605] {aka DIP, Dsip1, Gilz, TSC-22R, Tilz3}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Slc2a1 (solute carrier family 2 (facilitated glucose transporter), member 1) [NCBI Gene 20525] {aka GT1, Glut-1, Glut1, M100200, Rgsc200}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Prl3b1 (prolactin family 3, subfamily b, member 1) [NCBI Gene 18776] {aka Csh2, Ghd8, PL, Pl-2, Pl2, mPL-II}, Shcbp1 (Shc SH2-domain binding protein 1) [NCBI Gene 20419] {aka mPAL}, Igf1r (insulin-like growth factor I receptor) [NCBI Gene 16001] {aka A330103N21Rik, CD221, D930020L01, IGF-1R, hyft}, l9Rl2 (lethal, Chr 9, Russell 2) [NCBI Gene 117203] {aka pl-2}, Tfap2c (transcription factor AP-2, gamma) [NCBI Gene 21420] {aka AP2gamma, Ap-2.2, Stra2, Tcfap2c}, Sgk1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 20393] {aka Sgk}, Pcdh12 (protocadherin 12) [NCBI Gene 53601] {aka Pcdh14, VE-cad-2}, Tpbpa (trophoblast specific protein alpha) [NCBI Gene 21984] {aka Tb-1, Tb1, Tpbp, b2b1247Clo}, Rn18s (18S ribosomal RNA) [NCBI Gene 19791], Car9 (carbonic anhydrase 9) [NCBI Gene 230099] {aka CAIX, Ca9, MN/CA9}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Tfap2a (transcription factor AP-2, alpha) [NCBI Gene 21418] {aka AP-2, AP2alpha, Ap-2 (a), Ap2, Ap2tf, Tcfap2a}, Cyp1a1 (cytochrome P450, family 1, subfamily a, polypeptide 1) [NCBI Gene 13076] {aka AHH, AHRR, CP11, CYPIA1, P450-1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}
- **Diseases:** weight gain (MESH:D015430), fetal hypoxemia (MESH:D000860), placental insufficiency (MESH:D010927), FGR (MESH:D005317), fetal death (MESH:D005313), anxiety (MESH:D001007), growth retardation (MESH:D006130), nausea (MESH:D009325), preterm birth (MESH:D047928), obesity (MESH:D009765), maternal hypothyroidism (MESH:D007037), pain (MESH:D010146), villous hyperplasia (MESH:D018253), placental dysfunction (MESH:D010922), diabetes (MESH:D003920)
- **Chemicals:** Delta9-tetrahydrocannabinol (MESH:D013759), paraffin (MESH:D010232), sodium azide (MESH:D019810), hydrogen peroxide (MESH:D006861), glycogen (MESH:D006003), flavonoids (MESH:D005419), PAHs (MESH:D011084), Tween20 (MESH:D011136), carbohydrates (MESH:D002241), pregnenolone (MESH:D011284), N2 (MESH:D009584), glucose (MESH:D005947), citrate (MESH:D019343), CBD (-), oxygen (MESH:D010100), ethanol (MESH:D000431), terpenes (MESH:D013729), 11-Nor-9-carboxy-THC (MESH:C016780), PFA (MESH:C003043), alcohol (MESH:D000438), Periodic acid (MESH:D010504), CBD (MESH:D002185), DAB (MESH:C000469), Cannabinoid (MESH:D002186), fat (MESH:D005223), xylene (MESH:D014992)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Cannabis (genus) [taxon 3482], Cannabis sativa (species) [taxon 3483], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097], Macaca mulatta (rhesus macaque, species) [taxon 9544]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12991273/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12991273/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC12991273/full.md

---
Source: https://tomesphere.com/paper/PMC12991273